You are viewing an obsolete version of the DU website which is no longer supported by the Administrators. Visit The New DU.
Democratic Underground Latest Greatest Lobby Journals Search Options Help Login
Google

Reply #9: Nothing to do with Cipro, but check this out [View All]

Printer-friendly format Printer-friendly format
Printer-friendly format Email this thread to a friend
Printer-friendly format Bookmark this thread
This topic is archived.
Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU
Mandate My Ass Donating Member (1000+ posts) Send PM | Profile | Ignore Wed Apr-14-04 02:18 PM
Response to Original message
9. Nothing to do with Cipro, but check this out
Edited on Wed Apr-14-04 02:21 PM by Monica_L
http://www.pot-tv.net/shows/1994.html

Another patent coup for Bayer plus it gives one a whole new perspective on Ashcroft's jihad against medical marijuana....


By Stephen Foley
The Independent (UK)


Geoffrey Guy has a conviction: possession of cannabis, with intent to supply. Not a criminal conviction, of course, since Dr Guy is an upstanding businessman and pillar of the community in Dorset. Just an evangelical belief that cannabis has an array of medical benefits and that his own painkiller, developed from the plant, will be available on the National Health within months.

He is the G in GW Pharmaceuticals, its founder, executive chairman, and cheerleader-in-chief. He saw that the Home Office was sympathetic to multiple sclerosis sufferers who had long argued cannabis had medical benefits, but that outright legalisation was a non-starter. So he asked for a license to grow the plant and, barely five years later, GW is tantalisingly close to launching its under-the-tongue spray, called Sativex.

Biopirates! Bayer and GW Merger...
-one step closer to a pot monopoly?


21 May 2003 - GW and Bayer Announce Marketing Agreement on Pioneering New Cannabis-based Treatment

GW Pharmaceuticals and Bayer AG have entered into an exclusive marketing agreement for GW’s cannabis-based medicinal extract product, to be marketed under the Sativex® brand name.

Bayer has obtained exclusive rights to market Sativex in the UK. In addition, Bayer has the option for a limited period of time to negotiate the marketing rights in other countries in European Union and selected other countries around the world.

They are teaming up to provide a "medically acceptable cannabis-derived product" for the treatment of MS and severe neuropathic pain. The product is a whole plant medicinal cannabis extract containing THC, or, as GW puts it, "tetranabinex" and CBD, or according to GW, "Nabidiolex" as its principal components. The medicine is administered by means of a spray into the mouth.
Printer Friendly | Permalink |  | Top
 

Home » Discuss » Archives » General Discussion (Through 2005) Donate to DU

Powered by DCForum+ Version 1.1 Copyright 1997-2002 DCScripts.com
Software has been extensively modified by the DU administrators


Important Notices: By participating on this discussion board, visitors agree to abide by the rules outlined on our Rules page. Messages posted on the Democratic Underground Discussion Forums are the opinions of the individuals who post them, and do not necessarily represent the opinions of Democratic Underground, LLC.

Home  |  Discussion Forums  |  Journals |  Store  |  Donate

About DU  |  Contact Us  |  Privacy Policy

Got a message for Democratic Underground? Click here to send us a message.

© 2001 - 2011 Democratic Underground, LLC